DI BONAVENTURA, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 12.323
EU - Europa 7.998
AS - Asia 6.995
Continente sconosciuto - Info sul continente non disponibili 1.000
SA - Sud America 779
AF - Africa 112
OC - Oceania 12
Totale 29.219
Nazione #
US - Stati Uniti d'America 12.052
SG - Singapore 2.782
CN - Cina 1.993
RU - Federazione Russa 1.451
IT - Italia 1.416
IE - Irlanda 998
UA - Ucraina 996
GB - Regno Unito 904
SE - Svezia 722
TR - Turchia 715
BR - Brasile 590
VN - Vietnam 563
FR - Francia 496
DE - Germania 467
IN - India 323
FI - Finlandia 213
HK - Hong Kong 141
CA - Canada 135
BD - Bangladesh 97
MX - Messico 74
JP - Giappone 69
AR - Argentina 64
ES - Italia 60
IQ - Iraq 57
PL - Polonia 50
NL - Olanda 47
AT - Austria 38
ZA - Sudafrica 37
CO - Colombia 32
KR - Corea 31
EC - Ecuador 29
VE - Venezuela 26
CH - Svizzera 25
ID - Indonesia 25
CZ - Repubblica Ceca 23
SA - Arabia Saudita 21
PH - Filippine 20
BE - Belgio 19
PK - Pakistan 19
MA - Marocco 18
MY - Malesia 18
IL - Israele 15
LT - Lituania 15
JM - Giamaica 14
LB - Libano 13
CL - Cile 12
CR - Costa Rica 12
UZ - Uzbekistan 12
EG - Egitto 11
EU - Europa 11
IR - Iran 11
KE - Kenya 11
TH - Thailandia 11
JO - Giordania 10
AE - Emirati Arabi Uniti 9
PY - Paraguay 9
EE - Estonia 8
PE - Perù 8
TN - Tunisia 8
AU - Australia 7
RS - Serbia 7
GR - Grecia 6
NP - Nepal 6
UY - Uruguay 6
DK - Danimarca 5
KZ - Kazakistan 5
NI - Nicaragua 5
OM - Oman 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
DZ - Algeria 4
HN - Honduras 4
RO - Romania 4
SN - Senegal 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
AL - Albania 3
AO - Angola 3
BG - Bulgaria 3
CG - Congo 3
DO - Repubblica Dominicana 3
HR - Croazia 3
NZ - Nuova Zelanda 3
PA - Panama 3
TW - Taiwan 3
BH - Bahrain 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
KG - Kirghizistan 2
LV - Lettonia 2
MQ - Martinica 2
NG - Nigeria 2
PR - Porto Rico 2
SC - Seychelles 2
SI - Slovenia 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 28.205
Città #
Singapore 1.983
San Jose 1.468
Chandler 1.323
Jacksonville 1.202
Dublin 993
Ashburn 700
Dearborn 642
Southend 574
Dallas 551
Beijing 511
Princeton 475
Council Bluffs 406
Izmir 376
Nanjing 344
Los Angeles 294
Santa Clara 220
Chieti 201
Wilmington 184
Cambridge 183
Ho Chi Minh City 179
Buffalo 166
Tongling 151
New York 136
The Dalles 132
Hong Kong 127
Nanchang 125
Altamura 120
Ann Arbor 113
Moscow 113
Hanoi 112
Boardman 90
Rome 90
Munich 87
Kunming 71
Orem 67
São Paulo 65
Pescara 64
Phoenix 63
Shenyang 60
Hebei 59
Redondo Beach 58
Tokyo 54
Dong Ket 49
Milan 48
Washington 47
Chicago 46
Jiaxing 45
Woodbridge 42
Brooklyn 40
Tianjin 40
Montreal 39
Atlanta 38
Chennai 38
Warsaw 38
Hefei 37
Norwalk 36
Toronto 36
Columbus 35
Houston 35
Boston 34
Silver Spring 33
Vienna 32
Da Nang 29
Frankfurt am Main 29
Kimball 29
Stockholm 29
Changsha 28
Amsterdam 27
Nuremberg 27
Denver 25
Pune 24
Hangzhou 23
Seattle 23
Johannesburg 22
Poplar 22
San Francisco 22
Memphis 21
Mumbai 21
Seoul 21
Augusta 20
Baghdad 20
Civitanova Marche 20
Grevenbroich 20
Jinan 20
Mexico City 20
Haiphong 19
Rio de Janeiro 19
San Mateo 19
Brussels 18
London 18
Guangzhou 17
Orange 17
Zhengzhou 17
Ankara 16
Düsseldorf 16
Shanghai 16
Ancona 15
Dhaka 15
Helsinki 15
Turku 15
Totale 16.514
Nome #
Adhesion and biofilm formation by Staphylococcus aureus clinical isolates under conditions relevant to the host: Relationship with macrolide resistance and clonal lineages 866
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp. pasteurianus 230
Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: Microbiological, clinical and economic evaluation 212
Corynebacterium glucuronolyticum causing genitourinary tract infection: Case report and review of the literature 205
Streptococcus dysgalactiae subsp. equisimilis: two cases of tonsillitis. 196
Attività battericida ed anti-biofilm di peptidi antimicrobici verso patogeni multi-resistenti isolati da pazienti con fibrosi cistica. 192
Effetto post-antibiotico di levofloxacina e grepafloxacina nei confronti di Stenotrophomonas maltophilia. 188
Efficacy of phages and antibiotic-phage combinations against biofilm by Pseudomonas aeruginosa from cystic fibrosis patients 181
Absence of Helicobacter pylori in tonsillar swabs from dyspeptic patients. 179
Unusual oropharyngeal asymptomatic manifestations caused by atypical pathogens detected by PCR into altered ecosystems of an infertile couple. 177
Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection. 175
An overview on streptococcus bovis/streptococcus equinus complex isolates: Identification to the species/subspecies level and antibiotic resistance 172
Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm 168
Colonic adenoma-associated Escherichia coli express specific phenotypes 165
Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. 164
Antibiotic resistance and biofilm in Stenotrophomonas maltophilia isolates from cystic fibrosis and non-cystic fibrosis patients 163
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 160
Optimal combination of media for primary isolation of Helicobacter pylori from gastric biopsy specimens. 158
A novel biotechnology product for the degradation of biofilm-associated polysaccharides produced by Streptococcus mutans 157
Analisi proteomica del biofilm formato da un ceppo di Stenotrophomonas maltophilia isolato da fibrosi cistica. 154
Detection of Helicobacter pylori by PCR on gastric biopsy specimens taken for CP test: comparison with histopathological analysis. 152
First report of an acute purulent maxillary sinusitis caused by Pseudomonas aeruginosa secondary to dental implant placement in an immunocompetent patient. 152
A new challenge in cystic fibrosis antimicrobial therapy: activity of electrochemically synthesized silver nanoparticles against planktonic and biofilm cells of bacterial pathogens 152
In vitro microbiology studies on a new peritoneal dialysis connector 151
Accuracy of flagella’s staining in the diagnosis of Helicobacter pylori infection: comparative study with the hystology, culture, and rapid urease test. 149
Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: In vitro and in vivo studies 149
A European perspective on intravascular catheter-related infections: report on the microbiology workload, aetiology and antimicrobial susceptibility (ESGNI-005 Study). 148
Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains 147
Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime. 145
Meticillin-heteroresistant Staphylococcus pasteuri from an apheresis platelet product 143
An overview of various typing methods for clinical epidemiology of the emerging pathogen Stenotrophomonas maltophilia. 143
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp pasteurianus 143
Effect of levofloxacin on Stenotrophomonas maltophilia biofilm and its relationship with SmeDEF multidrug efflux pump expression under conditions relevant to the cystic fibrosis lung 142
Comparison of Etest, agar dilution, broth microdilution and disk diffusion methods for testing in vitro activity of levofloxacin against Staphylococcus spp. isolated from neutropenic cancer patients 140
Accuratezza di Etest per lo studio di attività in vitro di combinazioni tra fluorochinoloni e cefalosporine di terza generazione verso Pseudomonas aeruginosa. 139
Characterization of biofilm formation by Myroides odoratimimus isolated from post-traumatic calcaneal recurrent ulcer in diabetic patient 139
Monitoraggio microbiologico di aria e superfici in ambiente di prime cure chirurgiche di ambulatorio INAIL. 138
Alterazione dei livelli tessutali di ioni metallici in un modello murino di infezione polmonare da Stenotrophomonas maltophilia. 138
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 138
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus 137
Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis. 137
New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formed by a human wound-associated strain. 137
Microbiological Laboratory Diagnosis of Human Brucellosis: An Overview 136
Aumentati livelli mucosali gastrici di IL-1alfa, IL-6 ed IL-8 in pazienti Helicobacter pylori-positivi affetti da cardiopatia ischemica. 135
Effect of environmental factors on biofilm formation by clinical Stenotrophomonas maltophilia strains. 134
Accuratezza di E test nella determinazione in vitro della sensibilità di stafilococchi isolati da pazienti neutropenici verso levofloxacina. 134
Nuovi sistemi emocolturali automatici, ESP 128 (Difco) e Bact/Alert (Organon Teknika): analisi comparativa. 134
Helicobacter pylori Outer Membrane Vesicles (OMVs) as DNA shuttles and structural components of biofilm EPS 134
Microbial cooperation in cystic fibrosis: Stenotrophomonas maltophilia significantly modulates Pseudomonas aeruginosa virulence. 134
A case ofpharyngitis caused by Streptococcus pneumoniae. 134
Two cases of vaginitis caused by itraconazole-resistant saccharomyces cerevisiae and a review of recently published studies. 133
Ottimale sopravvivenza di Actinobacillus actinomycetemcomitans sotto varie condizioni di trasporto. 131
Accuratezza di E test per il monitoraggio dell’antibiotico-sensibilità di Pseudomonas aeruginosa isolati da pazienti sottoposti a cateterismo vescicale. 131
Development of a nanocomposite membrane based on reduced graphene (r-GO) and zeolite 13X for the removal of metal ions with bactericidal actions 131
Ulcer infection by ESbetaL-producing Proteus mirabilis: a case report. 130
Ricerca di Helicobacter pylori tramite PCR su biopsie gastriche sottoposte al test rapido all’ureasi (CP-test). 130
Isolamento di Actinobacillus actinomycetemcomitans nella placca sottogengivale di pazienti portatori di apparecchiature ortodontiche 130
Biofilm microbici come sistema dinamico in risposta allo stress ambientale. Approcci innovativi nella prevenzione e formulazione di nuove strategie terapeutiche integrate 129
Comparative in vitro activity of levofloxacin and ciprofloxacin against bacterial isolates from neutropenic patients. 129
Staphylococcus pasteuri bacteraemia in a patient with leukaemia. 129
Comparison of the E test to agar dilution and broth microdilution methods for quantitative antimicrobial susceptibility testing of Helicobacter pylori. 129
Sensibilità in vitro ai fluorichinoloni di Stenotrophomonas maltophilia isolati da pazienti neutropenici. 129
Anaerobiosi ed ambiente acido influenzano l’attività in vitro di colistina nei confronti del biofilm formato da ceppi di Pseudomonas aeruginosa isolati da pazienti affetti da fibrosi cistica. 129
Management and triage of women in follow-up for low-grade cervical disease: association of DNA and RNA-Based methods 128
Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans. 128
Usefulness of Leifson staining method in diagnosis of Helicobacter pylori infection. 128
In vitro activity of clarithromycin against intracellular Helicobacter pylori. 127
Normal breathing releases SARS-CoV-2 into the air 127
Evaluation of the E Test for Antimicrobial Susceptibility Testing of Pseudomonas aeruginosa Isolates from Patients with Long-Term Bladder Catheterization 126
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 125
Effetti dell’antibiotico-resistenza di H. pylori sulle terapie eradicanti. 125
null 125
Frequency of detection of Actinobacillus actinomycetemcomitans in young patients during fixed orthodontic therapy. 124
Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is their a relationship ? 124
Misidentification of ampicillin-sulbactam heteroresistance in Acinetobacter baumannii strains from ICU patients 124
Pan-azole-resistant Candida guilliermondii from a leukemia patient's silent funguria 124
Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study 124
In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions 124
In Vitro Viability of External Eye Microbial Flora in Hydroxy-Propyl-Methylcellulose 123
Effetto di concentrazioni sub-inibenti di moxifloxacina su Stenotrophomonas maltophilia isolati da fibrosi cistica 123
Antibiotico-resistenza di gram-negativi isolati in Terapia Intensiva nel triennio 1996-1998. 123
P Role of the antibiotic sensitivity test before helicobacter pylori eradication treatments in naive patients 123
Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector 123
Spiral and coccoid forms of H. pylori in gastric mucosa biopsies: an electron microscopy study. 123
Attività in vitro di roxitromicina in confronto con eritromicina verso Actinobacillus actinomycetemcomitans. 122
Hafnia alvei from the farm to the delivery room 122
Isolation of colistin-resistant Hafnia alvei. 121
Methicillin-resistant Staphylococcus pseudintermedius infection in a bone marrow transplant recipient 121
Attività in vitro di levofloxacina verso isolati clinici da pazienti neutropenici. 120
Exposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens 120
In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies. 120
Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient 120
In vivo bacterial cooperation in cystic fibrosis: exposure to Stenotrophomonas maltophilia affects Pseudomonas aeruginosa virulence in murine model of acute lung infection. 120
Cell surface hydrophobicity, motility, and biofilm formation of Stenotrophomonas maltophilia clinical isolates. 119
Subinhibitory concentrations ofmoxifloxacin decrease adhesion and biofilm formation of Stenotrophomonasmaltophilia from cystic fibrosis. 119
In vitro bactericidal and antibiofilm activity of six antimicrobial peptides against multidrug-resistant pathogens from patients with cystic fibrosis. 119
Myroides odoratimimus Forms Structurally Complex and Inherently Antibiotic-Resistant Biofilm in a Wound-Like in vitro Model. 119
An antimicrobial bicyclic peptide from chemical space against multidrug resistant Gram-negative bacteria 119
Identificazione di ceppi di Acinetobacter baumannii appartenenti a cloni epidemici mediante sequenziamento di geni coinvolti nella produzione di biofilm. 118
Produzione di biofilm in ceppi di Listeria monocytogenes isolati da matrice ittica: correlation con motilità ed idrofobicità cellulare. 118
Totale 14.724
Categoria #
all - tutte 114.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.191


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.149 0 0 0 218 107 22 43 111 122 40 143 343
2022/20233.433 288 423 215 416 341 652 203 261 441 42 99 52
2023/20241.468 122 75 90 46 116 381 368 71 16 48 10 125
2024/20253.743 248 614 464 115 88 146 136 159 472 184 441 676
2025/20268.769 590 344 874 885 848 429 1.518 619 1.417 688 424 133
2026/20271.889 299 442 499 649 0 0 0 0 0 0 0 0
Totale 29.219